Pharmacia & Upjohn Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: London United Kingdom (1995)
Status: Acquired by Pharmacia (2000) → now Pfizer (2003)

Organization Overview

First Clinical Trial
1995
NCT01422317
First Marketed Drug
1995
heparin (liquaemin)
First NDA Approval
1995
ibutilide (corvert)
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Pharmacia and Upjohn | PHARMACIA AND UPJOHN | PHARMACIA UPJOHN | Pharmacia & Upjohn Company LLC